semaglutide heart failure Efficacy and safety of in patients with with preserved ejection fraction and obesity - Rehman - 2024 - Clinical Cardiology Semaglutide improves heart failure symptoms

For most people, ghrelin levels normalize within 3 to 6 months of discontinuation

Antihypertensive and cardiovascular medications: Significant weight loss can lower blood pressure and improve cardiovascular risk factors, potentially necessitating dose reductions in antihypertensive agents to avoid hypotension

This scoping review aimed to identify and describe clinical evidence on renal outcomes associated with GLP-1-based therapies in adults with type 2 diabetes and/or overweight/obesity, with or without CKD

According to the findings, 97% of pharmacies are concerned that the introduction of an oral treatment could lead to an increase in counterfeit or unlicensed products being sold

Semaglutide offers significant benefits